Livongo Health
Livongo Health raises $105M Series E at $1.1B valuation
Quick Facts
Livongo Health: Series E Funding Round
Livongo Health has successfully raised $105M in Series E funding, reaching a valuation of $1.1B.
Company Overview
Chronic condition management platform
Funding Details
The Series E round was led by General Catalyst, with participation from Kleiner Perkins, Venrock, Kinnevik AB.
Company Information
- Headquarters: 150 West Evelyn Avenue, Mountain View, CA 94041
- Founded: 2014
- Employees: 1000+
- Category: HealthTech
Investment
Livongo Health plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- General Catalyst: Verified investor in Series E
- Kleiner Perkins: Verified investor in Series E
- Venrock: Verified investor in Series E
- Kinnevik AB: Verified investor in Series E
Key Investors
About the Author
Related Company Reports
Zingage raises $12.5M Seed at $60M valuation
Zingage raises $12.5M in Seed at $60M valuation. AI platform for home healthcare coordination and patient engagement...
AccelerateStack Platform raises $75M Series C at $226M valuation
AccelerateStack Platform secures $75M in Series C funding led by Intel Capital, reaching $226M valuation as it accelerates growth in the healthtech sector.
Duos raises $130M Growth Equity at $600M valuation
Duos raises $130M in Growth Equity at $600M valuation. Digital health platform for Medicare-focused patient care...